Inmunocaps

Enhancing the vaccinal immune response through the use of microencapsulated probiotics

Co-encapsulation of probiotics and vaccines to create a new product for human and animal health. This product derives from the synergy between probiotics and vaccines.

Sometimes vaccines do not have a good effect, due to problems with intestinal bacteria, being especially critical in the first years of life. An imbalance in the intestinal flora can predispose the immune system to not respond efficiently to vaccines.

NUCAPS NANOTECHNOLOGY will investigate a solution in the design of microcapsules that contain the vaccine together with probiotics to help them have the proper effect.

  • Title: INMUNOCAPS, Enhancing the vaccinal immune response through the use of microencapsulated probiotics. Co-encapsulation of probiotics and vaccines to create a new product for human health.
  • Identification number: 0011-1408-2020-000029
  • Implementation period: 2020 – 2023
  • Partners: NUCAPS NANOTECHNOLOGY (Proyecto financiado por convocatoria de Doctorandos industriales 2020 del Gobierno de Navarra y cofinanciado con fondos FEDER).